共 50 条
- [22] Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (04):
- [23] High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis Journal of Translational Medicine, 17
- [29] Serum sAPO-1/Fas levels in multiple sclerosis ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 (04): : 208 - 210
- [30] Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis Biological Trace Element Research, 2014, 158 : 276 - 279